ducovest

SOLV:NYE-Solventum Corp. (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 75.3

Change

+0.15 (+0.20)%

Market Cap

USD 13.78B

Volume

0.67M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Company Website : https://www.solventum.com

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
DOCS Doximity Inc

-1.12 (-1.79%)

 USD 13.23B
WEAV Weave Communications Inc

-0.33 (-2.88%)

 USD 0.83B
AMWL American Well Corp

-0.33 (-4.02%)

 USD 0.16B
CTEV Claritev Corporation

-0.05 (-0.25%)

 N/A
EVH Evolent Health Inc

+0.15 (+1.50%)

 N/A
PHR Phreesia Inc

+0.34 (+1.26%)

 N/A
TDOC Teladoc Inc

-0.48 (-5.41%)

 N/A
VEEV Veeva Systems Inc Class A

-0.53 (-0.22%)

 N/A
FOXO FOXO Technologies Inc.

-0.01 (-5.11%)

 N/A

ETFs Containing SOLV

INVN The Alger ETF Trust 2.45 % 0.00 %

-0.15 (-0.78%)

 N/A
XHE SPDR® S&P Health Care Eq.. 2.17 % 0.35 %

-0.83 (-0.78%)

 USD 0.18B
CSD Invesco S&P Spin-Off ETF 0.00 % 1.16 %

-0.76 (-0.78%)

 N/A
CSD Invesco S&P Spin-Off ETF 0.00 % 0.61 %

-0.76 (-0.78%)

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.99% 89% A- 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.99% 89% A- 91% A-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 13.78B 100% F 88% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector